Concepedia

U. Shukla

US

Statistics

Publications

4

Citations

173

H-Index

4

Active since

2003

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

Johnson & Johnson (United States)

U. Shukla is an author at Janssen (Belgium) specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

2003–2015

4

Publications

4

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

Gert Ulrich Kuerzel, U. Shukla, H. E. Scholtz et al. · Current Medical Research and Opinion · 2003 · 130 citations

, , +17

Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti‐MRSA fluoroquinolone JNJ‐Q2

Gary Eichenbaum, M Pugsley, DJ Gallacher et al. · British Journal of Pharmacology · 2012 · 15 citations · Full text

, , +17

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

Xavier Forns, Marina Berenguer, Kerstin Herzer et al. · Journal of Hepatology · 2015 · 15 citations

, , +17

Methods to evaluate and improve the injection site tolerability of intravenous formulations prior to first-in-human testing

Gary Eichenbaum, Junguo Zhou, Ann De Smedt et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 13 citations

, , +16

1–4 of 4